The size of the Global Pharmaceutical Membrane Filtration Market is valued at USD 7.52 billion in 2019 and is expected to grow at a CAGR of 11%, to reach USD 12.67 billion by 2024 during the forecast period 2019-2024. The micro-organism present during the purification and examining of medicinal preparations and also the organisms present in air and water as well which need vital membrane filtration process for a standard procedure.
Industry Overview
The membrane filtration is used for the purpose of filtering the drugs that during the development of the drug projects. Membrane filters are used for different applications like capsules prefilters and so on. Key players also play a major role in membrane filtration of pharmaceutical. Merck Millipore is also one of the key players in membrane filtration market that recommend complete sweep of filters and their systems.
Pall Corporation is one of the top leading key market players which provide a variety of separation, filtration and purification systems. It provides cartridge filters that offer the most flexible selection for pleated cartridge filters. Membrane products like that are economical and also serve a multi-functional purpose for variety of applications.
Alfa-Laval, has very refined performance in the industry. It is very economical and offers sustainable solutions and also used in blood plasma processing, pharmaceutical water systems and so on.
Key Market Drivers
The primary factor which significantly boosts the growth of the global pharmaceutical membrane filtration market is increasing applications of membrane filters in biopharmaceutical and pharmaceutical industries.
Wide-scale adoption of the Nanofiltration technology, steadily growing biopharmaceutical industry, as well as rapid development in generics production, are the attributable causes driving Global Pharmaceutical Membrane Filtration Market.
The increasing economies of the countries are helping the manufactures and key players to expand their distribution networks and productivity in manufacturing capabilities which are contributing to the growth of the pharmaceutical membrane filtration market.
The availability of advanced Nanofiltration techniques is another significant factor which is catalyzing the growth of the market.
Steadily increasing demand for single-use technologies is boosting the growth of the pharmaceutical membrane filtration market.
The adoption of effective and safe manufacturing practices by the companies is contributing to the growth of the global pharmaceutical membrane market.
Major Challenges
Operational costs of membrane filters are very high, resulting in the low adoption rate of these filters, which is a significant challenge for stakeholders and is limiting the growth of the pharmaceutical membrane filtration market.
The reluctance of manufacturers to adopt membrane filters due to regular maintenance issues and complicated procedures such as membrane fouling is another major challenge to the key players in the market which is restraining the growth of the pharmaceutical membrane filtration market.
Potential Opportunities
The emergence of advanced and innovative filtration techniques and systems are expected to create lucrative growth opportunities for key market players in the global pharmaceutical membrane filtration market during the forecast period.
Increasing demand for biopharmaceutical products is leading to an influx of investments for the research and development activities which are anticipated to boost the number of growth opportunities for the stakeholders operating in the pharmaceutical membrane filtration market.
Increasing economies of developed and developing nations like China, Brazil, India, Japan is leading to the expansion of the pharmaceutical industry in these regions and is supposed to offer more growth opportunities for the key players functioning in the market.
Recent happenings in this market:
REPORT COVERAGE
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2018 – 2024 |
|
Base Year |
2018 |
|
Forecast Period |
2019 - 2024 |
|
Segments Covered |
By Product, Technique, Application, Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Market Leaders Profiled |
Merck KGaA (Germany), General Healthcare Company (U.K.), Pall Corporation (U.S.), Sartorius Stedim Biotech Group (France), Alfa Laval (Sweden), Graver Technologies, LLC (U.S.), Koch Membrane Systems Inc. (U.S.), GEA Group (Germany), and Novasep (U.S.) |
This research report on the Global Pharmaceutical Membrane Filtration Market has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2024.
Pharmaceutical Membrane Filtration Market Analysis - By Product:
Pharmaceutical Membrane Filtration Market Analysis - By Technique:
On the basis of technique, the MCE membrane filters category is estimated to account for the biggest market share in 2016. This is majorly attributed to the high adoption rate of membrane filtration products. The microfiltration category is estimated to grow at the highest CAGR during the aforementioned forecast period. This can be attributed to the high rates of production of pharmaceutical products and drugs. The final product processing category is estimated to grow at the highest rate during the aforementioned forecast period.
Pharmaceutical Membrane Filtration Market – By Application:
Regional Analysis:
Presently, North America accounts for the largest market share while Asia Pacific has the highest CAGR. Growth in North America is basically due to the increasing instances of cases of airborne diseases which result in higher production generic drug production.
List of key market participants dominating the Global Pharmaceutical Membrane Filtration Market covered in this report are:
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 MCE Membrane Filters
5.1.2 Coated Cellulose Acetate Membrane Filters
5.1.3 Nylon Membrane Filters
5.1.4 PTFE Membrane Filters
5.1.5 PVDF Membrane Filters
5.1.6 Other Membrane Filters
5.1.7 Y-o-Y Growth Analysis, By Product
5.1.8 Market Attractiveness Analysis, By Product
5.1.9 Market Share Analysis, By Product
5.2 Technique
5.2.1 Microfiltration
5.2.2 Ultrafiltration
5.2.3 Nanofiltration
5.2.4 Crossfiltration
5.2.5 Reverse Osmosis
5.2.6 Ion Exchange
5.2.7 Y-o-Y Growth Analysis, By Technique
5.2.8 Market Attractiveness Analysis, By Technique
5.2.9 Market Share Analysis, By Technique
5.3 Application
5.3.1 Final Product Processing
5.3.2 Raw Material Filtration
5.3.3 Cell Separation
5.3.4 Water Purification
5.3.5 Air Purification
5.3.6 Y-o-Y Growth Analysis, By Application
5.3.7 Market Attractiveness Analysis, By Application
5.3.8 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Technique
6.1.3.4 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Technique
6.1.4.4 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Technique
6.1.5.4 By Application
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Novasep
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Merck KGaA (Germany)
8.3 GE Healthcare Company (U.K.)
8.4 Pall Corporation (U.S.)
8.5 Sartorius Stedim Biotech Group (France)
8.6 Alfa Laval (Sweden)
8.7 Graver Technologies
8.8 LLC (U.S.)
8.9 Koch Membrane Systems Inc. (U.S.)
8.10 GEA Group (Germany)
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
